Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: Gastroenterology. 2017 Apr 9;153(1):219–232. doi: 10.1053/j.gastro.2017.04.002

Fig. 4.

Fig. 4

Clinical disease parameters associated with RNASET2 disease-risk variants and expression levels. (A) Survival analysis for time between prior and index surgeries based upon carriage for IBD-risk variant rs9355610 for 154 CD patients who underwent multiple surgeries. (B–C) Expression of RNASET2 by RNA-seq for 71 CD patients based upon (B) IgG ASCA sero-positivity. (C) Montreal disease classification (B1, B2, and B3).